More News

28 Aug 2019 Machavert Pharmaceuticals Signs Exclusive License Agreement to Control RAL GTPase Inhibitors against KRAS Cancers
28 Aug 2019 Ionis licenses hepatitis B program to GSK
27 Aug 2019 Adaptimmune and Noile-Immune Announce Agreement to Develop SPEAR T-Cell Products expressing IL-7 and CCL19 as a next-generation treatment for cancer patients
27 Aug 2019 Zogenix Announces Acquisition of Modis Therapeutics, Inc.
27 Aug 2019 Bristol-Myers Squibb Announces Agreement Between Celgene and Amgen to Divest OTEZLA® for $13.4 Billion
22 Aug 2019 Innovent Enters a Licensing Agreement with Lilly to Develop & Commercialize a Novel Diabetes Medicine in China
20 Aug 2019 Alligator Bioscience Signs Antibody Agreement for Greater China with Biotheus Inc.
20 Aug 2019 OKYO Pharma Announces Collaboration with Prof. Pedram Hamrah to Evaluate Proprietary Lead Compounds as Non-Opioid Analgesics Targeting G-Protein Coupled Receptors
15 Aug 2019 Phio Pharmaceuticals and Helmholtz Zentrum München to Collaborate on Novel Targets for the Use of Self-Delivering RNAi In T Cell and NK Cell Adoptive Cell Therapy Therapeutics
14 Aug 2019 Ultragenyx Announces Partnership with GeneTx to Advance Treatment for Angelman Syndrome
13 Aug 2019 AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio
13 Aug 2019 Jazz Pharmaceuticals Announces Acquisition of Cavion, Inc.
13 Aug 2019 Pharming acquires exclusive license to CDZ173, a late stage drug for the treatment of APDS
12 Aug 2019 Boehringer Ingelheim and MD Anderson form unique Virtual Research and Development Center to rapidly advance new cancer therapies
12 Aug 2019 RELIEF THERAPEUTICS Holding SA Announces Divestment of its Subsidiary Relief Therapeutics SA to Sonnet BioTherapeutics, Inc. to Ensure the Development of Atexakin Alpha (Interleukin-6)
12 Aug 2019 AC Immune Announces Research Collaboration with University of Pennsylvania Focusing on Pathogenic Protein TDP-43 in Neurodegenerative Diseases
08 Aug 2019 Bayer acquires BlueRock Therapeutics to build leading position in cell therapy
06 Aug 2019 Aquinox Pharmaceuticals and Neoleukin Therapeutics announce merger agreement
05 Aug 2019 Neuropore Therapies and BenevolentAI Enter Strategic Collaboration to Discover Novel Therapeutics Through the Application of Artificial Intelligence
05 Aug 2019 Sosei Heptares and Takeda Enter Into New Strategic Multi-target Research, Development and Commercialization Partnership
01 Aug 2019 ImCheck Therapeutics Awarded €2 Million From Bpifrance to Advance its First-in-class Immunotherapy Program Into the Clinic
01 Aug 2019 Rewind Therapeutics Awarded €2.9 Million VLAIO Grant to Discover and Develop Novel Drug Candidates for Myelin-related Neurological Diseases
01 Aug 2019 Exelixis and Aurigene Enter Into Exclusive Collaboration, Option and License Agreement to Discover and Develop Novel Therapies for Cancer
31 Jul 2019 REGENXBIO Announces New License Agreement with Pfizer for the Treatment of Friedreich's Ataxia Using NAV® AAV9 Vector
31 Jul 2019 Alizé Pharma 3 raises €67 million ($75 million) in Series A from a strong international syndicate

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up